Half Year 2025 Cochlear Ltd Earnings Call Transcript
Key Points
- Cochlear Ltd (CHEOF) reported a 13% increase in Cochlear implant revenue and a 22% rise in Acoustics revenue, contributing to a 6% net sales increase in constant currency.
- The company achieved a 7% increase in underlying net profit, reaching $206 million, aligning with sales growth.
- Cochlear Ltd (CHEOF) maintained a strong balance sheet with $383 million in cash, despite inventory build-up for new product launches.
- The dividend increased by 8% to $2.15, reflecting a commitment to shareholder returns.
- The company is on track to help over 50,000 people with implants this year, maintaining its guidance range, albeit at the lower end due to specific challenges.
- Services revenue declined by 12%, attributed to cost of living pressures and higher cancellation rates, particularly in the US.
- Operating expenses increased by 10%, outpacing sales growth, due to continued investment in R&D and growth initiatives.
- Emerging markets underperformed expectations, with only 3% growth in the first half, partly due to delayed tenders in countries like India.
- The company anticipates coming in at the lower end of its guidance range due to lower services revenue and increased cloud spending.
- Chengdu manufacturing site is still in ramp-up stage, contributing to a slight headwind in gross margin, expected to persist for another year or two.
Thank you for standing by, and welcome to the Cochlear Limited half year '25 results analyst and media briefing. (Operator Instructions). I'd now like to hand the conference over to Mr. Dig Howitt, CEO and President. Please go ahead.
Good morning everyone, and thanks for joining for our half year results presentation. Here with me today I have Stu Sayers and Sarah Thom. And Stu who was our CFO until the end of December and is now President of Asia Pacific and Latin America. We'll talk about the result because it's the result for the last half. And Sarah, as our new CFO, is here with me as well.
Okay. So thanks for joining. Let's get underway. And we have our mission upfront because that does guide all that we do at Cochlear and it also sets out our longer-run ambition and underpins our long-term strategy for growth. So looking back at the first half of this year.
Overall, we were pretty happy with the outcome. But clearly, as you look into it, there's some
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
